$911 Million is the total value of Rhenman & Partners Asset Management AB's 88 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 14.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | LILLY ELI & CO | $36,010,933 | – | 105,700 | +100.0% | 3.95% | – | |
| UNH | Buy | UNITED HEALTH GROUP INC | $35,724,560 | +77.3% | 76,000 | +100.0% | 3.92% | +86.6% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $29,760,000 | +9.9% | 600,000 | +2.6% | 3.27% | +15.7% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $28,808,250 | +7.9% | 35,500 | -4.1% | 3.16% | +13.6% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $26,065,360 | +12.8% | 83,500 | +4.4% | 2.86% | +18.8% |
| ANTM | Buy | ELEVANCE HEALTH INC | $25,699,520 | +11.3% | 56,000 | +24.4% | 2.82% | +17.2% |
| MRK | Buy | MERCK & CO. INC | $25,526,720 | +7.0% | 241,000 | +12.1% | 2.80% | +12.6% |
| BDX | Buy | BECTON DICKINSON & CO | $25,007,340 | +18.5% | 102,000 | +22.9% | 2.74% | +24.7% |
| COO | Buy | COOPER COS INC | $24,987,960 | +60.8% | 68,000 | +44.7% | 2.74% | +69.2% |
| ABBV | Buy | ABBVIE INC | $24,003,840 | +14.3% | 152,000 | +16.9% | 2.64% | +20.2% |
| ABC | Sell | AMERISOURCEBERGEN CORP | $23,741,660 | -17.2% | 149,000 | -13.9% | 2.61% | -12.9% |
| THC | Sell | TENET HEALTHCARE CORP | $23,616,000 | +2.8% | 410,000 | -12.9% | 2.59% | +8.2% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $23,081,770 | +4.8% | 41,000 | +2.5% | 2.53% | +10.3% |
| MCK | Buy | MCKESSON CORP | $22,182,360 | +51.6% | 62,000 | +59.0% | 2.44% | +59.6% |
| HCA | Sell | HCA HEALTHCARE INC | $21,792,960 | +0.9% | 84,000 | -6.7% | 2.39% | +6.2% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $21,738,000 | +6.6% | 150,000 | +17.2% | 2.39% | +12.1% |
| CI | Buy | CIGNA CORP NEW | $21,470,605 | +4.5% | 84,500 | +36.3% | 2.36% | +10.0% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $21,440,250 | -18.4% | 225,000 | -11.4% | 2.35% | -14.2% |
| GILD | Sell | GILEAD SCIENCES INC | $21,095,550 | -9.0% | 259,000 | -4.1% | 2.32% | -4.2% |
| MDT | Sell | MEDTRONIC PLC | $18,607,300 | -31.6% | 235,000 | -32.9% | 2.04% | -28.0% |
| ABT | Buy | ABBOTT LABS | $18,329,800 | +42.7% | 185,000 | +58.1% | 2.01% | +50.1% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $14,829,120 | -14.5% | 76,000 | +4.1% | 1.63% | -10.1% |
| AXNX | Buy | AXONICS INC | $14,748,483 | +2.5% | 271,062 | +17.9% | 1.62% | +7.9% |
| HUM | Sell | HUMANA INC | $14,650,800 | -26.7% | 30,000 | -23.1% | 1.61% | -22.8% |
| SWAV | Buy | SHOCKWAVE MEDICAL INC | $14,348,720 | +48.5% | 67,000 | +42.6% | 1.58% | +56.2% |
| BIIB | Buy | BIOGEN INC | $13,068,675 | +57.3% | 47,500 | +58.3% | 1.44% | +65.5% |
| CVS | Buy | CVS HEALTH CORP | $12,923,100 | -18.9% | 173,000 | +1.2% | 1.42% | -14.7% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $12,213,700 | +18.1% | 185,000 | -7.5% | 1.34% | +24.3% |
| NTRA | Buy | NATERA INC | $11,774,420 | +77.6% | 217,000 | +31.5% | 1.29% | +86.8% |
| BNTX | Sell | BIONTECH SEsponsored ads | $11,276,440 | -31.1% | 92,000 | -15.6% | 1.24% | -27.5% |
| DHR | Sell | DANAHER CORPORATION | $11,241,000 | -15.3% | 45,000 | -10.0% | 1.23% | -10.9% |
| PRVA | Buy | PRIVIA HEALTH GROUP INC | $10,861,059 | +29.3% | 395,667 | +6.9% | 1.19% | +35.9% |
| OM | Buy | OUTSET MED INC | $10,242,400 | +10.2% | 560,000 | +55.6% | 1.12% | +15.9% |
| INSP | Sell | INSPIRE MED SYS INC | $9,137,296 | -40.5% | 38,392 | -37.1% | 1.00% | -37.4% |
| SILK | Buy | SILK RD MED INC | $8,613,457 | -16.8% | 221,255 | +13.0% | 0.95% | -12.4% |
| SGEN | SEAGEN INC | $8,326,280 | +58.0% | 41,000 | 0.0% | 0.91% | +66.2% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $7,888,350 | -42.0% | 215,000 | -28.3% | 0.87% | -38.9% |
| TXG | Buy | 10X GENOMICS INC | $7,807,500 | +185.7% | 150,000 | +100.0% | 0.86% | +200.7% |
| PFE | Sell | PFIZER INC | $7,672,200 | -57.2% | 190,000 | -45.7% | 0.84% | -55.0% |
| PODD | Sell | INSULET CORP | $7,605,120 | -10.9% | 24,000 | -17.2% | 0.84% | -6.3% |
| RVNC | Sell | REVANCE THERAPEUTICS INC | $7,159,900 | -11.4% | 230,000 | -47.5% | 0.79% | -6.9% |
| CYTK | Sell | CYTOKINETICS INC | $7,013,050 | -29.2% | 205,000 | -5.2% | 0.77% | -25.5% |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $6,996,250 | -16.1% | 725,000 | -7.5% | 0.77% | -11.7% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $6,944,700 | -31.6% | 70,000 | -17.6% | 0.76% | -28.0% |
| XNCR | Sell | XENCOR INC | $6,850,000 | -10.5% | 250,000 | -15.0% | 0.75% | -5.9% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $6,667,400 | +13.1% | 37,000 | +23.3% | 0.73% | +19.0% |
| ISEE | Sell | IVERIC BIO INC | $6,655,600 | -27.7% | 280,000 | -34.9% | 0.73% | -23.9% |
| VEEV | Buy | VEEVA SYS INC | $6,628,550 | +19.1% | 37,000 | +7.2% | 0.73% | +25.3% |
| IMCR | Sell | IMMUNOCORE HLDGS PLCads | $6,238,806 | -27.1% | 131,288 | -12.5% | 0.68% | -23.3% |
| ALHC | Buy | ALIGNMENT HEALTHCARE INC | $6,230,000 | +63.0% | 1,000,000 | +207.7% | 0.68% | +71.4% |
| RPRX | Sell | ROYALTY PHARMA PLC | $5,989,500 | -29.5% | 165,000 | -23.3% | 0.66% | -25.7% |
| EXAS | Sell | EXACT SCIENCES CORP | $5,963,400 | +9.5% | 90,000 | -18.2% | 0.66% | +15.3% |
| ITCI | Sell | INTRA-CELLULAR THERAPIES INC | $5,885,250 | -11.0% | 105,000 | -16.0% | 0.65% | -6.4% |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $5,709,900 | -46.9% | 70,000 | -51.4% | 0.63% | -44.1% |
| HRMY | Sell | HARMONY BIOSCIENCES HLDGS IN | $5,555,600 | -58.0% | 170,000 | -29.2% | 0.61% | -55.8% |
| WST | Sell | WEST PHARMACEUTICAL SVSC INC | $5,113,050 | -13.1% | 15,000 | -40.0% | 0.56% | -8.6% |
| IMGN | Sell | IMMUNOGEN INC | $4,637,500 | -37.7% | 1,250,000 | -16.7% | 0.51% | -34.4% |
| GKOS | Buy | GLAUKOS CORP | $4,531,000 | +22.0% | 92,000 | +8.2% | 0.50% | +28.4% |
| Sell | R1 RCM INC | $4,485,000 | +8.4% | 300,000 | -20.6% | 0.49% | +13.9% | |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $4,219,946 | -23.6% | 686,170 | -20.6% | 0.46% | -19.6% |
| IQV | Buy | IQVIA HLDGS INC | $4,093,950 | -0.1% | 21,000 | +5.0% | 0.45% | +4.9% |
| TECH | Sell | BIO-TECHNE CORP | $3,983,650 | -46.6% | 55,000 | -38.9% | 0.44% | -43.8% |
| HCAT | Buy | HEALTH CATALYST INC | $3,869,200 | +102.2% | 340,000 | +88.9% | 0.42% | +112.5% |
| OLK | Sell | OLINK HLDG ABsponsored ads | $3,799,740 | -23.0% | 174,300 | -10.3% | 0.42% | -19.0% |
| ALKS | Sell | ALKERMES PLC | $3,755,700 | -4.2% | 135,000 | -10.0% | 0.41% | +0.7% |
| PHR | Sell | PHREESIA INC | $3,702,000 | -23.7% | 120,000 | -20.0% | 0.41% | -19.8% |
| VRAY | VIEWRAY INC | $3,320,000 | -25.9% | 1,000,000 | 0.0% | 0.36% | -22.1% | |
| VKTX | New | VIKING THERAPEUTICS INC | $3,119,400 | – | 180,000 | +100.0% | 0.34% | – |
| RLAY | Sell | RELAY THERAPEUTICS INC | $3,022,900 | +1.2% | 190,000 | -5.0% | 0.33% | +6.4% |
| MGTX | Sell | MEIRAGTX HLDGS PLC | $2,797,337 | -22.7% | 538,986 | -2.9% | 0.31% | -18.8% |
| NVCR | Buy | NOVOCURE LTD | $2,620,800 | +2.1% | 45,000 | +28.6% | 0.29% | +7.5% |
| Buy | NUVALENT INC | $2,542,000 | +6.7% | 100,000 | +25.0% | 0.28% | +12.0% | |
| ISRG | Buy | INTUITIVE SURGICAL INC | $2,513,000 | +89.4% | 10,000 | +100.0% | 0.28% | +100.0% |
| BBIO | New | BRIDGEBIO PHARMA INC | $2,315,250 | – | 135,000 | +100.0% | 0.25% | – |
| ARVN | ARVINAS INC | $2,278,850 | -21.6% | 85,000 | 0.0% | 0.25% | -17.5% | |
| AGL | Sell | AGILON HEALTH INC | $2,103,300 | -48.9% | 90,000 | -64.7% | 0.23% | -46.2% |
| NTLA | INTELLIA THERAPEUTICS INC | $1,801,000 | +3.2% | 50,000 | 0.0% | 0.20% | +8.8% | |
| IGMS | Buy | IGM BIOSCIENCES INC | $1,616,900 | +90.1% | 95,000 | +90.0% | 0.18% | +100.0% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INC | $1,551,175 | -15.6% | 1,157,593 | -5.5% | 0.17% | -11.5% |
| ESPR | ESPERION THERAPEUTICS INC NE | $1,503,000 | -73.2% | 900,000 | 0.0% | 0.16% | -71.8% | |
| ALLO | Sell | ALLOGENE THERAPEUTICS INC | $1,491,000 | -30.3% | 300,000 | -11.8% | 0.16% | -26.5% |
| MRSN | Sell | MERSANA THERAPEUTICS INC | $1,400,000 | -40.3% | 350,000 | -12.5% | 0.15% | -37.1% |
| EPIX | Sell | ESSA PHARMA INC | $1,051,675 | +11.3% | 356,500 | -4.9% | 0.12% | +16.2% |
| STXS | Sell | STEREOTAXIS INC | $952,683 | -42.3% | 493,618 | -38.1% | 0.10% | -39.0% |
| AXSM | New | AXSOME THERAPEUTICS INC | $908,250 | – | 15,000 | +100.0% | 0.10% | – |
| NKTX | NKARTA INC | $680,000 | -43.2% | 200,000 | 0.0% | 0.08% | -40.0% | |
| SGMO | Sell | SANGAMO THERAPEUTICS INC | $534,067 | -79.3% | 314,157 | -61.7% | 0.06% | -78.1% |
| Sell | RAPID MICRO BIOSYSTEMS INC | $165,298 | -51.2% | 127,152 | -57.6% | 0.02% | -48.6% | |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -550,000 | -100.0% | -0.13% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.20% | – |
| GTHX | Exit | G1 THERAPEUTICS INC | $0 | – | -370,000 | -100.0% | -0.21% | – |
| PHAT | Exit | PHATHOM PHARMACEUTICALS INC | $0 | – | -235,210 | -100.0% | -0.28% | – |
| TDOC | Exit | TELADOC HEALTH INC | $0 | – | -130,000 | -100.0% | -0.32% | – |
| OSH | Exit | OAK STR HEALTH INC | $0 | – | -250,000 | -100.0% | -0.56% | – |
| NVST | Exit | ENVISTA HOLDINGS CORPORATION | $0 | – | -163,800 | -100.0% | -0.58% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -100,000 | -100.0% | -1.84% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -88,000 | -100.0% | -3.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.